EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate

Farzand Farhad Hamid Hamid

Health Innovation Reports · 2025

DOI: 10.64048/hir.v1n2.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Innovation Reports, 2025. Verfasst von Farzand Farhad Hamid Hamid. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic modifications, including DNA methylation, histone modification, and non-coding RNAs, play crucial roles in regulating gene expression without altering the underlying DNA sequence. In cancer, these epigenetic processes are often disrupted, contributing to tumor initiation, growth, metastasis, and drug resistance. This article reviews the latest findings on epigenetic dysregulation in cancer, emphasizing how these modifications influence tumor behavior and presenting novel therapeutic strategies aimed at targeting the epigenome. Additionally, we explore the potential for integrating epigenetic biomarkers into precision oncology to enhance patient outcomes, with a focus on recent advancements from 2022 to 2025.

Zitieren

APA

Hamid, F. F. H. (2025). Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate. Health Innovation Reports. https://doi.org/10.64048/hir.v1n2.007

Vancouver

Hamid FFH. Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate. Health Innovation Reports. 2025. doi:10.64048/hir.v1n2.007

BibTeX
@article{Hamid2025,
  author = {Hamid, Farzand Farhad Hamid},
  title = {Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate},
  journal = {Health Innovation Reports},
  year = {2025},
  doi = {10.64048/hir.v1n2.007}
}
Kostenlos starten →